Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;107(4):383-392.
doi: 10.1111/ejh.13688. Epub 2021 Jul 29.

The hemostatic and thrombotic complications of liver disease

Hannah Stowe McMurry  1 , Janice Jou  2 , Joseph Shatzel  3   4
Affiliations
Review

The hemostatic and thrombotic complications of liver disease

Hannah Stowe McMurry et al. Eur J Haematol. 2021 Oct.

Abstract

Hepatic cirrhosis leads to numerous hematologic derangements resulting in a complex and tenuously rebalanced hemostatic milieu. The utility of common hematologic tests including the INR and aPTT in assessing hemostatic and thrombotic risk in patients with cirrhosis is limited, and consensus on transfusion thresholds and proper management of thrombotic complications continues to evolve. This review summarizes the pathophysiology of key derangements of hemostasis including those of platelets, von Willebrand factor, pro- and anticoagulation factors, and fibrin. Additionally, the pathogenesis, consequences, optimal management, and prevention of major thrombotic and bleeding complications in cirrhosis arte discussed.

Keywords: blood coagulation; hemostasis; humans; liver cirrhosis; thrombosis.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None.

Figures

FIGURE 1
FIGURE 1
Pathogenesis of hematologic derangements of cirrhosis Created with biorender.com
See this image and copyright information in PMC

References

    1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;362:k2817. - PMC - PubMed
    1. Kujovich JL. Coagulopathy in liver disease: a balancing act. Hematology. 2015;2015(1):243–249. - PubMed
    1. Tripodi A, Mannucci PM. The Coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–156. - PubMed
    1. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878–885. - PubMed
    1. Rodríguez-Castro KI, Antonello A, Ferrarese A. Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? World J Hepatol. 2015;7(14):1818–1827. - PMC - PubMed

MeSH terms